About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
26 Aug,2024
Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
HANGZHOU, CHINA, August 20, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK), a leading player in China’s peripheral and neurovascular intervention markets, today announced its interim ...
more
22 Mar,2024
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
HANGZHOU, CHINA, March 21, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announc...
more
08 Mar,2024
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
HANGZHOU, CHINA, MAR 7th, 2024 – Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China, today announc...
more
22 Feb,2024
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Health and P...
more
29 Jan,2024
Zylox-Tonbridge’s ZYLOX Venous Stent System Receives NMPA Marketing Approval
On January 22nd, Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZYLOX Peripheral Venous St...
more
04 Jan,2024
Zylox-Tonbridge’s ZYLOX® Phoenix Peripheral Detachable Fibered Coil Embolization System Receives NMPA Marketing Approval
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZYLOX® Phoenix Peripheral Detachable Fiber...
more
